Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Research & Development
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
|
Research & Development
-¥25.4m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
Inner Mongolia BaoTou Steel Union Co Ltd
SSE:600010
|
Research & Development
-¥963m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
-69%
|
CAGR 10-Years
N/A
|
|
|
Baoshan Iron & Steel Co Ltd
SSE:600019
|
Research & Development
-¥3.9B
|
CAGR 3-Years
31%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
|
W
|
Western Superconducting Technologies Co Ltd
SSE:688122
|
Research & Development
-¥383.6m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
N/A
|
|
|
C
|
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
|
Research & Development
-¥4.5B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
|
|
Inner Mongolia Dazhong Mining Co Ltd
SZSE:001203
|
Research & Development
-¥126.5m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View
Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.
See Also
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Research & Development?
Research & Development
-25.4m
CNY
Based on the financial report for Sep 30, 2025, Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Research & Development amounts to -25.4m CNY.
What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Research & Development growth rate?
Research & Development CAGR 3Y
-10%
Over the last year, the Research & Development growth was 23%. The average annual Research & Development growth rates for Xinjiang Bai Hua Cun Pharma Tech Co Ltd have been -10% over the past three years .
